Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Neuropsychiatric Disease and Treatment Volume 14, 2018 - Issue

Submit an article Journal homepage

Open access

110

Views

CrossRef citations to date

Altmetric

Original Research

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

Hideyuki Imagawa1 Medical Development Unit Japan, Eli Lilly Japan K.K., Kobe, JapanCorrespondence[email protected]

Saurabh P Nagar2 RTI Health Solutions, Research Triangle Park, NC, USA

William Montgomery3 Global Patient Outcomes and Real World Evidence, Eli Lilly Australia, NSW, Australia

Tomomi Nakamura1 Medical Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan

Masayo Sato1 Medical Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan

Keith L Davis2 RTI Health Solutions, Research Triangle Park, NC, USA

Pages 611-621 | Published online: 22 Feb 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Daniel Fife, Erica A. Voss, Jill Hardin, Hany Rofael, Ira D. Solomon, Patrick B. Ryan & Paul Stang. (2021) Medications for attention‐deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance. Neuropsychopharmacology Reports 41:3, pages 385-392.
Crossref

Eonjeong Kim, Susin Park, Yewon Kim & Nam Kyung Je. (2020) Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change. International Clinical Psychopharmacology 35:6, pages 329-337.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references